LABORATORY INFORMATICS


“Genomics saves lives, and I’m determined the UK stays at the forefront of this vital new technology”


maintain and develop our global leadership in this field, to realise the full potential offered by genomics,’ Lord Bethell added. This first phase implementation plan


follows on from Genome UK: the Future of Healthcare published in 2020, which set out a vision to create the most advanced genomic healthcare system in the world, to deliver better healthcare at lower cost. Genomics is just one example of the


government’s commitment to driving forward health innovation in the UK, which will be central to the future health resilience, the growth of the UK’s life sciences sector and improving patient care.


programmes and data-sharing initiatives, placing the UK at the forefront of secure sharing of international genomic and health-related data. Matt Hancock, the UK’s Health


Secretary, said: ‘We will transform the UK into a life sciences superpower. We’ll build on the success story of our life sciences during the pandemic, which has led the world in everything from vaccine development, to finding effective treatments that work, to genomic sequencing. ‘Today we’ve published our Genome UK implementation plan for how we can build on this even further, including our commitment to sequence one million whole genomes. Because genomics saves lives, and I’m determined the UK stays at the forefront of this vital new technology,’ Hancock continued. ‘If we draw on ingenuity like this, we can keep


www.scientific-computing.com | @scwmagazine


up the fight against Covid-19, and also tackle the other things that stop us living healthier lives like cancer, dementia and heart disease. ‘So, we’re increasing UK investment


in research and development, bringing much more of the supply chain onshore, sparing no effort to attract the brightest innovators and the best manufacturers,’ he concluded. Minister for Innovation Lord Bethell


said: ‘The UK has a proud history in developing genetic and genomic technologies which improve the lives of patients across the country and globally. ‘This implementation plan demonstrates the great strides we have already made since the launch of Genome UK, and outlines the actions we are taking to progress key commitments over the next year. ‘It is vital that we continue to


Chris Wigley, Genomics England CEO, said: ‘Since the days of Darwin, Rosalind Franklin, Crick and Watson, and Fred Sanger, the UK has been at the forefront of genomic science. With this publication it’s exciting to see the next chapter of that story coming to life. Our ecosystem has come together as never before through the difficult times of the pandemic – and this implementation plan will allow us to build on this collaboration between all of the world-leading genomics institutions in the UK.’ Professor Dame Sue Hill, NHS England’s Chief Scientific Officer, said: ‘The NHS is already a global leader in genomics and has introduced a range of new cutting-edge tests for people with rare diseases and cancer over the last year, despite the pandemic. ‘Genomics can truly transform the


way patient care is delivered, helping to predict and prevent disease, personalise treatments and ultimately save lives.’


Understanding Covid-19 In February 2021, the UK’s Covid-19 Genomics UK Consortium (COG UK) launched the COG-UK Mutation Explorer (COG-UK-ME) – an interface that provides access to data on Sars-CoV-2 mutations and variants of interest in the COG-UK genome sequence dataset. COG-UK-ME allows anyone to view information about important changes in the Sars-CoV-2 genome over time. The tool is updated twice weekly, and


largely focuses on spike gene mutations g Spring 2021 Scientific Computing World 21


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42